Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashDeferred TaxesDepreciation & Amortization (CF)Free Cash FlowNet Cash FlowNet IncomeShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Avalo Therapeutics (AVTX) Non-cash Items (2016)

Historic Non-cash Items for Avalo Therapeutics (AVTX) over the last 2 years, with Q3 2016 value amounting to $657099.0.

  • Avalo Therapeutics' Non-cash Items rose 4947.42% to $657099.0 in Q3 2016 from the same period last year, while for Sep 2016 it was $657099.0, marking a year-over-year increase of 4947.42%. This contributed to the annual value of $604167.0 for FY2015, which is N/A changed from last year.
  • Per Avalo Therapeutics' latest filing, its Non-cash Items stood at $657099.0 for Q3 2016, which was up 4947.42% from $642541.0 recorded in Q2 2016.
  • Avalo Therapeutics' 5-year Non-cash Items high stood at $657099.0 for Q3 2016, and its period low was $439607.0 during Q3 2015.